IMVT vs. NARI

Last updated Apr 1, 2026

Compare and contrast key facts about Immunovant, Inc. (IMVT) and Inari Medical, Inc. (NARI).

Performance

IMVT vs. NARI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immunovant, Inc. (IMVT) and Inari Medical, Inc. (NARI). The values are adjusted to include any dividend payments, if applicable.

IMVT vs. NARI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
IMVT Immunovant, Inc.	-2.28%	2.62%	-41.21%	137.35%	108.33%	-81.55%	130.83%
NARI Inari Medical, Inc.	0.00%	56.65%	-21.36%	2.14%	-30.36%	4.56%	105.34%

Fundamentals

Total Revenue (TTM) IMVT : $0.00 NARI : $574.50M
Gross Profit (TTM) IMVT : -$105.00K NARI : $494.08M
EBITDA (TTM) IMVT : -$372.49M NARI : -$36.16M

Returns By Period

IMVT

• 1D: 5.48%
• 1M: -10.42%
• YTD: -2.28%
• 6M: 54.09%
• 1Y: 45.35%
• 3Y*: 17.00%
• 5Y*: 8.07%
• 10Y*: —

NARI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

IMVT vs. NARI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMVT

IMVT Risk / Return Rank: 69
IMVT Sharpe Ratio Rank: 69
IMVT Sortino Ratio Rank: 69
IMVT Omega Ratio Rank: 63
IMVT Calmar Ratio Rank: 72
IMVT Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMVT vs. NARI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Inari Medical, Inc. (NARI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IMVT	NARI	Difference
Sharpe ratio Return per unit of total volatility	0.82	—	—
Sortino ratio Return per unit of downside risk	1.55	—	—
Omega ratio Gain probability vs. loss probability	1.17	—	—
Calmar ratio Return relative to maximum drawdown	1.59	—	—
Martin ratio Return relative to average drawdown	3.36	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	IMVT	NARI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.82	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.09	—	—

Correlation

The correlation between IMVT and NARI is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

IMVT vs. NARI - Dividend Comparison

Neither IMVT nor NARI has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	IMVT	NARI	Difference
Max Drawdown Largest peak-to-trough decline	-93.59%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-20.98%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-79.94%	—	—
Current Drawdown Current decline from peak	-52.87%	—	—
Average Drawdown Average peak-to-trough decline	-54.24%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	10.49%	—	—

Volatility

Volatility by Period

	IMVT	NARI	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.73%	—	—
Volatility (6M) Calculated over the trailing 6-month period	37.06%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	56.17%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	75.18%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	77.70%	—	—

Financials